key: cord-0889245-x7bb77bp authors: Wei, Xiao‐Shan; Wang, Xu; Ye, Lin‐Lin; Niu, Yi‐Ran; Peng, Wen‐Bei; Wang, Zi‐Hao; Zhang, Jian‐Chu; Zhou, Qiong title: Pleural effusion as an indicator for the poor prognosis of COVID‐19 patients date: 2021-03-16 journal: Int J Clin Pract DOI: 10.1111/ijcp.14123 sha: e5eab7da43ff761f208ca792d89147fda7e77d2e doc_id: 889245 cord_uid: x7bb77bp BACKGROUND: Coronavirus Disease 19 (COVID‐19) is a global health concern that has become a pandemic over the past few months. This study aims at understanding the clinical manifestations of COVID‐19 patients with pleural effusion. METHODS: COVID‐19 patients were retrospectively enrolled from the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Pharyngeal swabs from patients were tested using real‐time polymerase chain reaction. Patients with COVID‐19 were divided into two groups based on their computed tomography (CT) scans for the presence of pleural effusion at admission. We compared the clinical features, laboratory findings, scans and clinical outcomes between the two groups. RESULTS: Pleural effusion was observed in 9.19% of the patients. Patients with pleural effusion were more likely to be severe or critical cases. Moreover, patients with pleural effusion were associated with increased mortality. Of the 799 discharged patients, patients with pleural effusion had longer hospital stays and duration of viral shedding since the onset of symptoms as compared with that for patients without pleural effusion. After discharge, 217 patients visited for a follow‐up CT re‐examination at the Union Hospital. The CT scans showed that patients with pleural effusion required a longer time to resolve the lung inflammation after the onset of COVID‐19 as compared with the time required by patients without pleural effusion. CONCLUSION: This population of patients requires special attention and pleural effusion may be an indicator of poor prognosis in COVID‐19 patients. less likely to exhibit pleural effusions. 5 However, pleural effusion has been observed in severe and critical patients with COVID-19 as compared with that in moderate cases. 6, 7 Moreover, pleural effusion is associated with a high rate of mortality and longer hospital stay for patients with community-acquired pneumonia. 8 Thus, whether pleural effusion indicates the poor prognosis of COVID-19 pneumonia remains to be investigated. In this study, we analysed the differences between the clinical manifestations, laboratory examinations, imaging features and clinical outcomes among COVID-19 patients with or without pleural effusion. We retrospectively selected confirmed COVID-19 patients admitted to the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology between the 20 January and 29 of February, 2020 for this study. Patients were confirmed based on the positive readout for SARS-CoV-2 nucleic acid in throat swabs using real-time polymerase chain reaction (RT-PCR). We collected the medical records of the enrolled patients, including clinical features, laboratory results, imaging and clinical outcomes. The extent of pneumonia of patients were assessed using the CT scoring system as following: each of the five lung lobes was visually scored on a scale of 0-5:0 indicating no involvement; 1, <5% involvement; 2, >5%-25% involvement; 3, 26%-49% involvement; 4, 50%-75% involvement and 5, >75% involvement. The total score of all the five lobes was each patient's CT score (range from 5 to 25). After they were discharged, 217 of these patients returned to the outpatient department of the Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. We also collected the computed tomography (CT) scans of the patients from their subsequent visits. Patients were followed up to 30 May 2020. Ethics approval was obtained from the institutional ethics board of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (approval #2020-0120). Oral consent was obtained from all the patients. The need for written informed consent was exempt as per the ethics approval (2020-0120). Throat swabs were tested for the presence of SARS-CoV-2 using RT-PCR as per the recommendation by the World Health Organization. 9 The patient specimens from the upper respiratory tract were collected in tubes pre-filled with virus preservatives. Continuous variables have been represented as mean ± standard deviation or median and interquartile range (IQR). Categorical variables have been summarised as counts and percentages for each patient category. Statistical significance between groups was determined using unpaired t-test or chi-squared test as appropriate. All statistical analyses were performed using SPSS22.0 (SPSS Inc). In all, 827 patients with COVID-19 pneumonia were included in this study ( On admission, patients with pleural effusion had lower levels of white blood cells, lymphocytes, platelets, haemoglobin and Albumin as compared with those in patients without pleural effusion (P < .05, Table 2 ). Moreover, the levels of neutrophil, Aspartate aminotransferase, Lactic dehydrogenase, Creatine kinase, Prothrombin time, Activated partial thromboplastin time, D-Dimer and Erythrocyte sedimentation rate in patients with pleural effusion were much higher than those in patients without pleural effusion were (P < .05, Table 2 ). There was a higher proportion of patients with pleural effusion and higher levels of C-reaction protein or Procalcitonin as compared with those without pleural effusion (P < .001, Table 2 ). Table 3 shows that COVID-19 patients with pleural effusion showed a higher IL-6, IL-10 and TNFα content and lower levels of CD8 + T cells (P < .01). According to CT image features, consolidation was more common in patients with pleural effusion as compared with that in patients without pleural effusion (47.37% vs 31.42%, P = .007; Table S1 ). Typical CT images are shown in Figure S1 . As shown in Table 4 , all patients were administered antiviral agents, including Arbidol, Alpha-interferon, Ribavirin and Lopinavir/ritonavir. There were no differences in drug therapy between these two groups. COVID-19 patients with pleural effusion were more likely to undergo high-flow nasal cannula oxygen therapy (13.16% vs 6.13%, P = .029), non-invasive mechanical ventilation (10.53% vs 2.93%, P = .004) and invasive mechanical ventilation (3.95% vs 0.67%, P = .030). Figure 1C ). Using univariate analysis, we find several variables that showed significant difference between COVID-19 patients with pleural effusion and those without, including older age, had an underlying illness of respiratory disease (Table S2 ). All underlying illness and other variables which showed statistical significance with P < .05 between two groups, were further processed using a multivariable logistic regression. As shown in Table S3 , older age, history of respiratory disease, lower level of platelet and ALB, higher level of PT, APTT, D-Dimer and TNFα were risk factors for pleural effusion in COVID-19 patients. To evaluate the risk factors associated with pleural effusion further, patients with and without pleural effusion were matched in a 1:2 ratio (76:152 patients) based on age, gender and comorbidity (Table S4 ). Fourteen factors from the univariate analysis were used as part of the multivariate analysis to identify reliable prognostic factors for pleural effusion in patients with COVID-19 (Tables S5 and S6 ). Low platelet counts and high levels of TNFα were risk factors for pleural effusion in COVID-19 (Table S6 ). In this retrospective cohort study, COVID-19 patients with radiologically defined pleural effusion at admission were older, more likely to Previous studies have shown pleural effusion in 5.3%-10.3% of COVID-19 patients. 6, 7, 11, 12 In accordance with this, we observed Host immune cells play a pivotal role in infectious diseases. We observed low levels of lymphocytes and CD8 + T cells in COVID-19 patients with pleural effusion as compared with those in patients without pleural effusion. Moreover, the duration of SARS-CoV-2 particle shedding was longer among patients with pleural effusion. Previous studies have shown that increased IL-10 content and decreased CD8 + T cells are associated with prolonged duration of SARS-CoV-2 shedding. 25 Further studies are warranted to explore the underlying mechanism(s) involved in dysregulated immunity and SARS-CoV-2 infection. Pleural effusion indicates severe pneumonia. 26 In this study, patients with pleural effusion were more likely to manifest with consolidation in CT scans at admission and required a longer time for the resolution of lung inflammation. The presence of consolidation indicated viral invasion into the respiratory epithelium, resulting in diffuse alveolar injury and inflammatory exudates. 7 Pleural effusion results from biological processes, such as increased interstitial oedema and capillary permeability. 27 In this study, multi-factor regression analysis showed that decreased platelet and increased TNFα contents may be risk factors for pleural effusion. TNFα is important for pleural inflammation and parapneumonic effusion. 28 However, this study has several limitations. In summary, COVID-19 patients with pleural effusion had higher rates of mortality, respiratory failure and ARDS, and experienced longer hospital stay. Thus, pleural effusion may serve as an indicator of poor prognosis among COVID-19 patients. Ethics approval was obtained from the institutional ethics board of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (approval #2020-0120). Oral consent was obtained from all the patients. The need for written informed consent was exempt as per the ethics approval (2020-0120). The authors declare that they have no competing interests. QZ and JCZ conceived the idea, designed and supervised the study, The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Xiao-Shan Wei https://orcid.org/0000-0003-0401-7531 Qiong Zhou https://orcid.org/0000-0002-3120-3017 Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT COVID-19 with different severities: a multicenter study of clinical features The clinical and chest CT features associated with severe and critical COVID-19 pneumonia Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans National Health Commission of the People's Republic of China CT imaging features of 4121 patients with COVID-19: a meta-analysis Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis Clinical characteristics and factors predicting respiratory failure in adenovirus pneumonia Clinical features and radiological findings of adenovirus pneumonia associated with progression to acute respiratory distress syndrome: a single center study in 19 adult patients The radiologic manifestations of H5N1 avian influenza Acute middle east respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19 Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) TNFα impairs rhabdoviral clearance by inhibiting the host autophagic antiviral response The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients Geriatric assessment and prognostic factors of mortality in very elderly patients with community-acquired pneumonia Pneumonia and empyema: causal, casual or unknown Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions Additional Supporting Information may be found online in the Supporting Information section. How to cite this article Pleural effusion as an indicator for the poor prognosis of COVID-19 patients